Results 191 to 200 of about 24,815 (217)
Some of the next articles are maybe not open access.
[Pleural clot ablation and fibrinolytic agents].
Annales francaises d'anesthesie et de reanimation, 1985Two patients presenting with an important intrapleural clot with cardiorespiratory repercussions were given in situ thrombolytic treatment after drainage with a suction tube had failed. The first patient was treated immediately after thoracophrenolaparotomy for hepatic surgery. Dissolution of the clot was obtained with two local injections of urokinase
J F, Brulé +5 more
openaire +2 more sources
Are We Using Fibrinolytic Agents Often Enough?
Annals of Internal Medicine, 1980Excerpt The development and acceptance of new pharmacologic approaches to treatment are often painstakingly slow.
openaire +2 more sources
Synthetic Fibrinolytic Agents Induction of Fibrinolytic Activity In Vitro
1978Various asymmetric organic anions have been shown to possess the important capacity to enhance the endogenous fibrinolytic activity in human plasma in vitro. Their further development may well permit induction with them of the thrombolytic activity in human blood in vivo resulting in intravascular clot (thrombi, emboli) dissolution (thrombolysis) by ...
openaire +1 more source
Managing anticoagulation and fibrinolytic agents
2002Abstract Anticoagulants and thrombolytic agents are widely used in many branches of medicine. These agents can be truly life-saving, but there is a narrow therapeutic margin and they can cause serious haemorrhagic complications.
openaire +1 more source
[Fibrinolytic agents--who benefits when?].
Therapeutische Umschau. Revue therapeutique, 1995Thrombolytic therapy mimics and enhances physiological fibrinolysis. The following substances are presently available for clinical use: the nonphysiological thrombolytics streptokinase, the APSAC (acylated plasminogen-streptokinase activator complex), the physiological plasminogen activators urokinase and tissue plasminogen activator (t-PA).
W, Weichert, E, Seifried
openaire +1 more source
[Fibrinolytics and defibrinating agents].
Phlebologie, 1976Therapeutic fibrinolysis represents the only logical means of curing thromboses, by assuring the destruction of the thrombus. This kind of therapy, which was introduced clincally over 10 years ago, has been used on only a limited scale because of the high risk of haemorrhage and the need for highly specialized laboratory control tests.
openaire +1 more source
Greater use of fibrinolytic agents urged
JAMA: The Journal of the American Medical Association, 1980The thrombolytic agents urokinase and streptokinase are safe and more effective than traditional anticoagulants in treating deep-vein thrombosis and pulmonary embolism in carefully selected patients, a panel of experts convened by the National Institutes of Health (NIH) has concluded.
openaire +1 more source
Fibrinolytic agents: pharmacology, indications and prescribing
Nurse Prescribing, 2011Fibrinolytic (thrombolytic) agents are used thrombolysis (clot breakdown) in several indications, including acute ST-elevation myocardial infarction, acute pulmonary embolism and acute ischaemic stroke. The pathophysiology of each condition is discussed, as well as indications for the use of fibrinolytic agents.
openaire +1 more source